Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases-Reference-Cited by-同舟云学术

Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases

Published:2018-09-26 Issue:12 Volume:93 Page:1461-1466
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Shah Sahrish¹,Pardanani Animesh¹,Elala Yoseph C.²,Lasho Terra L.¹,Patnaik Mrinal M.¹^ORCID,Reichard Kaaren K.³,Hanson Curtis A.³,Ketterling Rhett P.⁴,Tefferi Ayalew¹^ORCID

Affiliation:

1. Divisions of Hematology; Mayo Clinic; Rochester Minnesota

2. Department of Internal Medicine; John C. Edwards School of Medicine, Marshall University; West Virginia

3. Divisions of Hematopathology; Mayo Clinic; Rochester Minnesota

4. Divisions of Laboratory Genetics and Genomics Departments of Internal Medicine and Laboratory Medicine; Mayo Clinic; Rochester Minnesota

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.25265/fullpdf

Reference13 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

2. Cytogenetic studies and in vitro colony growth in patients with mastocytosis;Swolin;Blood,1987

3. Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis;Naumann;Genes Chromosomes Cancer,2018

4. Next-generation sequencing in systemic mastocytosis: derivation of a mutation-augmented clinical prognostic model for survival;Pardanani;Am J Hematol,2016

5. ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis;Pardanani;Br J Haematol,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis of systemic mastocytosis with cryptic deletion of TET2 and DNMT3A resulting from unbalanced translocation;British Journal of Haematology;2024-05-04

2. Review and Updates on Systemic Mastocytosis and Related Entities;Cancers;2023-11-28

3. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

4. The international consensus classification of eosinophilic disorders and systemic mastocytosis;American Journal of Hematology;2023-06-07

5. Indolent systemic mastocytosis and aleukemic mast cell leukemia: Subtle diagnostic differences with distinct management approaches;JAAD Case Reports;2023-06